Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (331-340 of 365) with videos related to

Pageof 37
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1996
An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptorM M Bilimoria, V J Assikis, H D Muenzner, et al.
Breast Cancer Research and Treatment|December 1, 1988
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsR R Love, R B Mazess, D C Tormey, et al.
European Journal of Cancer|February 1, 1981
Structural derivatives of tamoxifen and oestradiol 3-methyl ether as potential alkylating antioestrogensV C Jordan, L Fenuik, K E Allen, et al.
Cancer Research|September 15, 1993
Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometryJ N Sarkaria, D F Gibson, V C Jordan, et al.
Breast Cancer Research and Treatment|January 1, 1993
Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouseD F Gibson, D A Johnson, D Goldstein, et al.
Biochemical Pharmacology|September 23, 1998
Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expressionE F Nuwaysir, Y P Dragan, R McCague, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effectsD L Trump, K H Havlin, E M Messing, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 26, 1998
Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in ratsY P Dragan, R J Shimel, N Bahnub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic miceK Yao, E S Lee, D J Bentrem, et al.
Breast Cancer Research and Treatment|September 1, 1993
The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor modelD F Gibson, D A Johnson, S M Langan-Fahey, et al.
Pageof 37

Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1996
An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptorM M Bilimoria, V J Assikis, H D Muenzner, et al.
Breast Cancer Research and Treatment|December 1, 1988
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsR R Love, R B Mazess, D C Tormey, et al.
European Journal of Cancer|February 1, 1981
Structural derivatives of tamoxifen and oestradiol 3-methyl ether as potential alkylating antioestrogensV C Jordan, L Fenuik, K E Allen, et al.
Cancer Research|September 15, 1993
Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometryJ N Sarkaria, D F Gibson, V C Jordan, et al.
Breast Cancer Research and Treatment|January 1, 1993
Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouseD F Gibson, D A Johnson, D Goldstein, et al.
Biochemical Pharmacology|September 23, 1998
Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expressionE F Nuwaysir, Y P Dragan, R McCague, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effectsD L Trump, K H Havlin, E M Messing, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 26, 1998
Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in ratsY P Dragan, R J Shimel, N Bahnub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic miceK Yao, E S Lee, D J Bentrem, et al.
Breast Cancer Research and Treatment|September 1, 1993
The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor modelD F Gibson, D A Johnson, S M Langan-Fahey, et al.
Pageof 37